Pictured (L-R): Richard Bruton TD (Minister for Jobs , Enterprise and Innovation), Douglas A Batt (senior vice president and general councel, Parexel) and Martin Shanahan (CEO IDA Ireland).
The global biopharmaceutical services provider to grow office to 200 jobs in next 12 to 18 months in Kilmainham, Dublin 8.
Parexel plans to hire an additional 130 people over the next 12 to 18 months across all areas of their business – clinical, technology, legal, consulting, and logistics – and at all levels, including senior decision-making roles in their Kilmainham location. 70 employees are in place, and recruitment is underway for the new positions.
Making the announcement Minister for Jobs, Enterprise and Innovation Richard Bruton TD, said: “Life sciences is a key sector which we have targeted as part of our Action Plan for Jobs, and in recent years we have seen an impressive jobs performance in this area, both in Dublin and across the country. Today’s announcement that Parexel is adding 130 jobs in Kilmainham is a great boost and an example of the wide range of different types of jobs that Ireland can attract in this sector.
“Europe is important to our growth and business strategy, and Ireland specifically is a key country from which we can better serve our customers and continue our growth,” said Douglas A Batt, senior vice president and general counsel, Parexel. “This office will be a global decision-making hub for our Company. Senior leaders based here will be making strategic decisions for the Company worldwide, and this office will play a critical role in continuing to bring Parexel’s global brand to the world.”
Welcoming Parexel’s decision to locate this strategically important part of its global business in Ireland, Martin Shanahan, CEO, IDA Ireland said: Parexel’s decision to locate in Ireland is an endorsement of the skills available to biopharmaceutical companies here. Ireland is the perfect place in which to locate a Global Hub – our location facilitates access into Europe, the Middle East and further afield. IDA Ireland has targeted the Life Sciences, and in particular, the Biopharmaceuticals sector for several years now – Parexel will be joining a very large cluster of biopharma companies that have already chosen Ireland as a place to locate business.